PTPA and cancer: In summary, these findings indicate that DT-061 mediates TFE3 dephosphorylation via PP2A, subsequentially promoting the transcriptional activation of ATF4 and CHOP that drives irreversible ISR phenotypes and triggers pro-death signals in cancer cells.